medwireNewsMutation-directed CAR T cell therapy feasible in recurrent glioblastomamedwireNewsmedwireNews: Treatment with autologous chimeric antigen receptor (CAR) T cells directed against the epidermal growth factor receptor variant III (EGFRvIII) mut… Continue reading
Phys.OrgS. Korea stem cell scandal official resignsPhys.OrgPark, a former biology professor seen as a key figure in a scandal involving the fabrication of research by prominent stem cell scientist Hwang Woo-Suk, had been under heavy pressure to step do… Continue reading
The Hans India |
Immunotherapy promising for type 1 diabetes
WebMD.Boots.com 11th August 2017 – Immunotherapy is similar to a desensitisation technique already in use for allergies, and now researchers say it is showing promise for delaying the progression of type 1 diabetes. According to the results of a clinical trial, it may … Immunotherapy may be safe for treating diabetesThe Hans India |
|
BrisSynBio start-up wins Unit DX lab space at Bio-Start Awards 2017
University of Bristol Zentraxa is the first start-up from the University of Bristol’s Synthetic Biology Research Centre, BrisSynBio, part of the Bristol BioDesign Institute. Focusing on the biomolecular design and engineering aspects of synthetic biology, it has been … |
University of Bristol |
BrisSynBio start-up wins Unit DX lab space at Bio-Start Awards 2017
University of Bristol Zentraxa is the first start-up from the University of Bristol’s Synthetic Biology Research Centre, BrisSynBio, part of the Bristol BioDesign Institute. Focusing on the biomolecular design and engineering aspects of synthetic biology, it has been … |
|
Searching in the immune checkpoint black box
Nature.com Similarly, loss of Ptpn2 also sensitized tumours to immunotherapy in vivo. Ptpn2-null B16 tumours were significantly more sensitive to PD1 inhibition — but did not show any growth disadvantage in the absence of T cell-mediated immunity or PD1 inhibition. |